Dilated Cardiomyopathy: From Genetics to Clinical Management
Open accessThe DOI matches its Crossref record; 605 of the 607 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
This open access book presents a multidisciplinary comprehensive overview of dilated cardiomyopathy, from pathophysiology, differential diagnosis work-up, to clinical management. It further highlights open issues such as the clinical use of genetic testing and arrhythmia in dilated cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bolli, R., Chugh, A. R., D'Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., Beache, G. M., Wagner, S. G., Leri, A., Hosoda, T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61590-0 · Cited by 1,288
RetractedYaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 1×
“Another cell-based strategy involves the production and in vitro expansion of CMs from human embryonic stem cells or iPSCs [8].”
BackgroundMcDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 12,362
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029 · cited 2×
“ACEi [29, 32, 33], ARB [34, 35], beta-blocker [36–38], and MRA [39, 40] have demonstrated, in several clinical trials, to reduce risk of HF hospitalization and death in patient with HF and reduced EF.”
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552 · cited 8×
“The forms of hereditary DCM in humans in which the genetic basis has been identified include mutations in the intermediate filament protein desmin, responsible for familial cardiac and skeletal myopathy (desmin-related myopathy),5 which also can be caused by a mutation in the αβ-crystalline gene associated with lens c…”
InfluentialThe Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,276 · cited 1×
“In the CARE-HF study, CRT reduced all-cause mortality, and the survival benefit with CRT-D over an implantable ICD was consistent in a subgroup analysis of patients with ischemic and nonischemic DCM [62].”
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Rose, E. A., Gelijns, A. C., Moskowitz, A. J., Heitjan, D. F., Stevenson, L. W., Dembitsky, W., Long, J. W., Ascheim, D. D., Tierney, A. R., Levitan, R. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa012175 · Cited by 3,977 · cited 1×
“This MCS, historically used only for short periods as bridge-totransplantation, nowadays is being used increasingly also as a permanent treatment or “destination therapy” [75].”
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
(1996) · Circulation · doi:10.1161/01.cir.93.5.841 · Cited by 3,458 · cited 1×
“According to the WHO definition, active myocarditis is present with immunohistochemical detection of focal or diffuse mononuclear infiltrates (T lymphocytes and macrophages) using a cut-off of >14 cells per mm2, in addition to increased expression of HLA class II molecules [26].”
MethodMaron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,436
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906431 · Cited by 3,157 · cited 2×
“Since then, many trials have demonstrated that CRT, in appropriately selected patients, reduces mortality and morbidity [58] and improves systolic function, symptoms, and quality of life [59, 60].”
Evidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., Dubourg, O., Kuhl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 3,010 · cited 1×
“One of the major challenges in nonischemic Dilated Cardiomyopathy (DCM) is the complex and heterogeneous etiology of the disease [1].”
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927 · cited 1×
“ACEi [29, 32, 33], ARB [34, 35], beta-blocker [36–38], and MRA [39, 40] have demonstrated, in several clinical trials, to reduce risk of HF hospitalization and death in patient with HF and reduced EF.”
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
Kim, R. J., Fieno, D. S., Parrish, T. B., Harris, K., Chen, E.-L., Simonetti, O., Bundy, J., Finn, J. P., Klocke, F. J., & Judd, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.19.1992 · Cited by 2,581 · cited 1×
“Areas of LGE detected by CMR correlate well with histologically detected regional myocardial fibrosis in animal models and human explanted hearts [41, 42].”
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Friedrich, M. G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., White, J. A., Abdel-Aty, H., Gutberlet, M., Prasad, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.007 · Cited by 2,509
Catheter Ablation for Atrial Fibrillation with Heart Failure
Marrouche, N. F., Brachmann, J., Andresen, D., Siebels, J., Boersma, L., Jordaens, L., Merkely, B., Pokushalov, E., Sanders, P., Proff, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1707855 · Cited by 2,492
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
An integrated semiconductor device enabling non-optical genome sequencing
Rothberg, J. M., Hinz, W., Rearick, T. M., Schultz, J., Mileski, W., Davey, M., Leamon, J. H., Johnson, K., Milgrew, M. J., Edwards, M., et al. (2011) · Nature · doi:10.1038/nature10242 · Cited by 2,172
Results of the Predictors of Response to CRT (PROSPECT) Trial
Chung, E. S., Leon, A. R., Tavazzi, L., Sun, J.-P., Nihoyannopoulos, P., Merlino, J., Abraham, W. T., Ghio, S., Leclercq, C., Bax, J. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.743120 · Cited by 2,161
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A., Dyer, A., Daubert, J. P., Quigg, R., Estes, N. A. M., Anderson, K. P., Calkins, H., Hoch, D., Goldberger, J., Shalaby, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,080
Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,078 · cited 1×
“Specific cardiomyopathies have been recognized as leading causes of sport-related cardiac arrest such as hypertrophic cardiomyopathy in the USA and arrhythmogenic right ventricular cardiomyopathy in Italy [18, 19].”
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70271-6 · Cited by 2,053
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924
Mancini, D. M., Eisen, H., Kussmaul, W., Mull, R., Edmunds, L. H., & Wilson, J. R. (1991) · Circulation · doi:10.1161/01.cir.83.3.778 · Cited by 1,882
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Tang, A. S. L., Wells, G. A., Talajic, M., Arnold, M. O., Sheldon, R., Connolly, S., Hohnloser, S. H., Nichol, G., Birnie, D. H., Sapp, J. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009540 · Cited by 1,859
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Defibrillator implantation in patients with nonischemic systolic heart failure
Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608029 · Cited by 1,763
Lancellotti, P., Tribouilloy, C., Hagendorff, A., Popescu, B. A., Edvardsen, T., Pierard, L. A., Badano, L., Zamorano, J. L., & On behalf of the Scientific Document Committee of the European Association of Cardiovascular Imaging: Thor Edvardsen, O. B. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet105 · Cited by 1,734
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,723
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
Myocarditis. A histopathologic definition and classification.
Aretz, H. T., Billingham, M. E., Edwards, W. D., Factor, S. M., Fallon, J. T., Fenoglio, J. J., Olsen, E. G. J., & Schöen, F. J. (1987) · PubMed · Cited by 1,587
Rhythm control versus rate control for atrial fibrillation and heart failure
Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708789 · Cited by 1,585 · cited 1×
“Rhythm control with antiarrhythmic drugs is not superior to rate control in patients with coexisting HF and AF [46].”
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Self-citationAckerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.020 · Cited by 1,479
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479
Diagnostic Accuracy of Noninvasive Coronary Angiography Using 64-Slice Spiral Computed Tomography
Raff, G. L., Gallagher, M. J., O’Neill, W. W., & Goldstein, J. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.056 · Cited by 1,472
Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts
Chong, J. J. H., Yang, X., Don, C. W., Minami, E., Liu, Y.-W., Weyers, J. J., Mahoney, W. M., Van Biber, B., Cook, S. M., Palpant, N. J., et al. (2014) · Nature · doi:10.1038/nature13233 · Cited by 1,408
Packer, M., Fowler, M. B., Roecker, E. B., Coats, A. J. S., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Staiger, C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035653.72855.bf · Cited by 1,364
Fatkin, D., MacRae, C., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H. J., Spudich, S., De Girolami, U., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412302 · Cited by 1,359 · cited 2×
“Patients with LMNA mutations and DCM also have electrical instability (DCM+E), with supraventricular arrhythmias and atrioventricular block often present before systolic dysfunction.(3,24) In large DCM cohorts, LMNA mutations are present in ≈5% of patients.”
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192666 · Cited by 1,359
Mammalian heart renewal by pre-existing cardiomyocytes
Senyo, S. E., Steinhauser, M. L., Pizzimenti, C. L., Yang, V. K., Cai, L., Wang, M., Wu, T.-D., Guerquin-Kern, J.-L., Lechene, C. P., & Lee, R. T. (2013) · Nature · doi:10.1038/nature11682 · Cited by 1,343
Braunwald, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800239 · Cited by 1,257
Laflamme, M. A., & Murry, C. E. (2011) · Nature · doi:10.1038/nature10147 · Cited by 1,206
Hormones and Hemodynamics in Heart Failure
Schrier, R. W., & Abraham, W. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410806 · Cited by 1,199 · cited 1×
“Furthermore, ATII stimulates adrenal secretion of aldosterone which, together with vasopressin, reduces renal excretion of water and sodium [17], configuring an inappropriate ADH secretion syndrome.”
BackgroundGulati, A., Jabbour, A., Ismail, T. F., Guha, K., Khwaja, J., Raza, S., Morarji, K., Brown, T. D. H., Ismail, N. A., Dweck, M. R., et al. (2013) · JAMA · doi:10.1001/jama.2013.1363 · Cited by 1,179
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,164 · cited 1×
“Moreover, LGE extent is also associated with adverse outcomes [44].”
McCrohon, J. A., Moon, J. C. C., Prasad, S. K., McKenna, W. J., Lorenz, C. H., Coats, A. J. S., & Pennell, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000078641.19365.4c · Cited by 1,154
Dynamics of Cell Generation and Turnover in the Human Heart
Bergmann, O., Zdunek, S., Felker, A., Salehpour, M., Alkass, K., Bernard, S., Sjostrom, S. L., Szewczykowska, M., Jackowska, T., dos Remedios, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.026 · Cited by 1,133
EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
Lang, R. M., Badano, L. P., Tsang, W., Adams, D. H., Agricola, E., Buck, T., Faletra, F. F., Franke, A., Hung, J., Pérez de Isla, L., et al. (2012) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.11.010 · Cited by 1,129
Pinto, Y. M., Elliott, P. M., Arbustini, E., Adler, Y., Anastasakis, A., Böhm, M., Duboc, D., Gimeno, J., de Groote, P., Imazio, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv727 · Cited by 1,099
Corrado, D., Pelliccia, A., Bjørnstad, H. H., Vanhees, L., Biffi, A., Borjesson, M., Panhuyzen-Goedkoop, N., Deligiannis, A., Solberg, E., Dugmore, D., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi108 · Cited by 1,097
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., & Martin, J. F. (2011) · Science · doi:10.1126/science.1199010 · Cited by 1,092
Bellenger, N. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2011 · Cited by 1,040 · cited 1×
“SSFP cine imaging is currently regarded as the gold standard imaging technique for the evaluation of LV volume and systolic function [1, 2], as it is not affected by the geometric assumptions used in 2D echocardiography for the LV (such as the area-length method) [3] (Fig.”
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
Hershberger, R. E., Hedges, D. J., & Morales, A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.105 · Cited by 1,025
Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance
Mewton, N., Liu, C. Y., Croisille, P., Bluemke, D., & Lima, J. A. C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.013 · Cited by 984
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.
Silverman, K. J., Hutchins, G. M., & Bulkley, B. H. (1978) · Circulation · doi:10.1161/01.cir.58.6.1204 · Cited by 984 · cited 1×
“Interestingly, cardiac involvement is present in about 25% of patients with systemic sarcoidosis [17], but symptoms referable to cardiac sarcoidosis occur in only 5% of sarcoid patients [18, 19], and up to 50% of patients with granulomatous inflammation in the heart have no evidence of extracardiac disease.”
BackgroundPelliccia, A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi325 · Cited by 983
Phelan, D., Collier, P., Thavendiranathan, P., Popović, Z. B., Hanna, M., Plana, J. C., Marwick, T. H., & Thomas, J. D. (2012) · Heart · doi:10.1136/heartjnl-2012-302353 · Cited by 972
Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review
Haaf, P., Garg, P., Messroghli, D. R., Broadbent, D. A., Greenwood, J. P., & Plein, S. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-016-0308-4 · Cited by 959
A physical map of the human genome
The International Human Genome Mapping Consortium, Washington University School of Medicine, G. S. C., McPherson, J. D., Marra, M., Hillier, L., Waterston, R. H., Chinwalla, A., Wallis, J., Sekhon, M., Wylie, K., et al. (2001) · Nature · doi:10.1038/35057157 · Cited by 925 · cited 5×
“Myocardial uptake is strictly dependent on etiology: absent or mild in AL, present in ATTR, and variable in other rarer genetic forms [32].”
InfluentialKindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., Klingel, K., Kandolf, R., Sechtem, U., Cooper, L. T., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.074 · Cited by 919
Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis
Mahrholdt, H., Wagner, A., Deluigi, C. C., Kispert, E., Hager, S., Meinhardt, G., Vogelsberg, H., Fritz, P., Dippon, J., Bock, C. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.606509 · Cited by 869 · cited 1×
“If present in DCM, LGE is typically found in a mid-wall distribution without an apparent correlation to coronary perfusion territories [13, 14] (Fig.”
Curigliano, G., Cardinale, D., Suter, T., Plataniotis, G., de Azambuja, E., Sandri, M. T., Criscitiello, C., Goldhirsch, A., Cipolla, C., & Roila, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds293 · Cited by 865
Pathogenesis of Chronic Chagas Heart Disease
Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C., & Simões, M. V. (2007) · Circulation · doi:10.1161/circulationaha.106.624296 · Cited by 849 · cited 1×
“The chronic cardiac involvement manifests as Chagas cardiomyopathy, characterized by a chronic myocarditis that involves all cardiac chambers and damage to the conduction system [12].”
BackgroundCardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
Ruschitzka, F., Abraham, W. T., Singh, J. P., Bax, J. J., Borer, J. S., Brugada, J., Dickstein, K., Ford, I., Gorcsan, J., Gras, D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306687 · Cited by 825
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Kakkar, R., & Lee, R. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2660 · Cited by 794 · cited 1×
“Another biomarker of inflammation and fibrosis is sST2, a member of the interleukin (IL)-1 receptor-like family, that is secreted in response to myocardial strain and IL1 stimulation [46].”
BackgroundINTERMACS Profiles of Advanced Heart Failure: The Current Picture
Stevenson, L. W., Pagani, F. D., Young, J. B., Jessup, M., Miller, L., Kormos, R. L., Naftel, D. C., Ulisney, K., Desvigne-Nickens, P., & Kirklin, J. K. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.02.015 · Cited by 793 · cited 1×
“An important contribution to evaluation for candidacy to LVAD was the introduction of the INTERMACS classification, which categorizes patients for the purpose of risk assessment prior to LVAD implant or HT [79], ranging from 1 (cardiogenic shock) to 7 (advanced NYHA III), and describes patient’s clinical status in ter…”
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
Grothues, F., Moon, J. C., Bellenger, N. G., Smith, G. S., Klein, H. U., & Pennell, D. J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.005 · Cited by 776 · cited 2×
“CMR is considered the gold standard for noninvasive assessment of RV function [7, 8].”
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
Khan, M. N., Jaïs, P., Cummings, J., Di Biase, L., Sanders, P., Martin, D. O., Kautzner, J., Hao, S., Themistoclakis, S., Fanelli, R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708234 · Cited by 771 · cited 1×
“Catheter ablation is a wellestablished option for symptomatic atrial fibrillation that is resistant to drug therapy in patients with otherwise normal cardiac function, and various studies have shown that ablation is associated with positive outcomes in patients with heart failure [47].”
Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.
(1980) · Heart · doi:10.1136/hrt.44.6.672 · Cited by 760
The Right Ventricular Failure Risk Score
Matthews, J. C., Koelling, T. M., Pagani, F. D., & Aaronson, K. D. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.009 · Cited by 752
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González‐Juanatey, J. R., Harjola, V., Jankowska, E. A., et al. (2016) · Utrecht University Repository (Utrecht University) · Cited by 743
Iles, L., Pfluger, H., Phrommintikul, A., Cherayath, J., Aksit, P., Gupta, S. N., Kaye, D. M., & Taylor, A. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.049 · Cited by 736 · cited 1×
“Native T1 and ECV are increased, and post-contrast T1 is decreased in nonischemic DCM patients [81, 83, 84].”
Walsh, R., Thomson, K. L., Ware, J. S., Funke, B. H., Woodley, J., McGuire, K. J., Mazzarotto, F., Blair, E., Seller, A., Taylor, J. C., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.90 · Cited by 734
The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy
Nigro, G., Comi, L. I., Politano, L., & Bain, R. J. I. (1990) · International Journal of Cardiology · doi:10.1016/0167-5273(90)90082-g · Cited by 731 · cited 1×
“Patients with overt skeletal myopathy may have subclinical DCM, with “masking” of cardiac symptoms due to the activity imitations imposed by skeletal myopathy.(45) Alternatively, patients with cardiomyopathy may have unnoticed skeletal myopathy which may ultimately complicate advanced therapies such as cardiac transpl…”
Detection of Myocardial Damage in Patients With Sarcoidosis
Patel, M. R., Cawley, P. J., Heitner, J. F., Klem, I., Parker, M. A., Jaroudi, W. A., Meine, T. J., White, J. B., Elliott, M. D., Kim, H. W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.851352 · Cited by 719
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Hershberger, R. E., Lindenfeld, J., Mestroni, L., Seidman, C. E., Taylor, M. R. G., & Towbin, J. A. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.006 · Cited by 702 · cited 12×
“Accordingly, the importance of considering familial disease in DCM has been emphasized in recent consensus statements.(12,13) The study of affected kindreds has revealed familial DCM to be mostly inherited in an autosomal dominant fashion with characteristic age-dependent penetrance and variable clinical expression (F…”
InfluentialRelationship between burden of premature ventricular complexes and left ventricular function
Baman, T. S., Lange, D. C., Ilg, K. J., Gupta, S. K., Liu, T.-Y., Alguire, C., Armstrong, W., Good, E., Chugh, A., Jongnarangsin, K., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.03.036 · Cited by 676
D’Uva, G., Aharonov, A., Lauriola, M., Kain, D., Yahalom-Ronen, Y., Carvalho, S., Weisinger, K., Bassat, E., Rajchman, D., Yifa, O., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3149 · Cited by 657
Viral myocarditis—diagnosis, treatment options, and current controversies
Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
(2016) · New England Journal of Medicine · doi:10.1056/nejmc1602668 · Cited by 654
Codd, M. B., Sugrue, D. D., Gersh, B. J., & Melton, L. J. (1989) · Circulation · doi:10.1161/01.cir.80.3.564 · Cited by 640
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
Ware, J. S., Li, J., Mazaika, E., Yasso, C. M., DeSouza, T., Cappola, T. P., Tsai, E. J., Hilfiker-Kleiner, D., Kamiya, C. A., Mazzarotto, F., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505517 · Cited by 613
Sarnoff (1954) · doi:10.1161/01.cir.9.5.706 · Cited by 602
Wu, K. C., Weiss, R. G., Thiemann, D. R., Kitagawa, K., Schmidt, A., Dalal, D., Lai, S., Bluemke, D. A., Gerstenblith, G., Marbán, E., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.018 · Cited by 598
Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
Renu, K., V.G., A., P.B., T. P., & Arunachalam, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 588
Strickberger, S. A., Hummel, J. D., Bartlett, T. G., Frumin, H. I., Schuger, C. D., Beau, S. L., Bitar, C., & Morady, F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00297-3 · Cited by 586
Auricchio, A., Fantoni, C., Regoli, F., Carbucicchio, C., Goette, A., Geller, C., Kloss, M., & Klein, H. (2004) · Circulation · doi:10.1161/01.cir.0000118502.91105.f6 · Cited by 585
Rossi, A., Dini, F. L., Faggiano, P., Agricola, E., Cicoira, M., Frattini, S., Simioniuc, A., Gullace, M., Ghio, S., Enriquez-Sarano, M., et al. (2011) · Heart · doi:10.1136/hrt.2011.225789 · Cited by 572
Birnie, D. H., Nery, P. B., Ha, A. C., & Beanlands, R. S. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.605 · Cited by 569
Gorcsan, J., Abraham, T., Agler, D. A., Bax, J. J., Derumeaux, G., Grimm, R. A., Martin, R., Steinberg, J. S., Sutton, M. S. J., & Yu, C.-M. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.01.003 · Cited by 564
Atlas of the clinical genetics of human dilated cardiomyopathy
Haas, J., Frese, K. S., Peil, B., Kloos, W., Keller, A., Nietsch, R., Feng, Z., Müller, S., Kayvanpour, E., Vogel, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu301 · Cited by 557
The Diagnosis and Evaluation of Dilated Cardiomyopathy
Japp, A. G., Gulati, A., Cook, S. A., Cowie, M. R., & Prasad, S. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.590 · Cited by 554
Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases
Corrado, D., Thiene, G., Nava, A., Rossi, L., & Pennelli, N. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90176-e · Cited by 552 · cited 1×
“SCD has been associated to competitive sport activity in the adolescents and young adult athletes [16, 17], with an increased risk compared with nonathletic counterparts [18].”
Leone, O., Veinot, J. P., Angelini, A., Baandrup, U. T., Basso, C., Berry, G., Bruneval, P., Burke, M., Butany, J., Calabrese, F., et al. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2011.10.001 · Cited by 535
Jefferies, J. L., & Towbin, J. A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62023-7 · Cited by 535
Cleland, J. G., Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Claude Daubert, J., Sherfesee, L., Wells, G. A., & Tang, A. S. L. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht290 · Cited by 525
Mutations in Cypher/ZASPin patients with dilated cardiomyopathy and left ventricular non-compaction
Vatta, M., Mohapatra, B., Jimenez, S., Sanchez, X., Faulkner, G., Perles, Z., Sinagra, G., Lin, J.-H., Vu, T. M., Zhou, Q., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.021 · Cited by 524 · cited 5×
“The ventricular dilation and DCM pattern is less common and almost always preceded by arrhythmias and/or conduction system defects [11, 12].”
InfluentialSelf-citationGhio, S., Recusani, F., Klersy, C., Sebastiani, R., Laudisa, M. L., Campana, C., Gavazzi, A., & Tavazzi, L. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00877-2 · Cited by 513
Tung, R., Vaseghi, M., Frankel, D. S., Vergara, P., Di Biase, L., Nagashima, K., Yu, R., Vangala, S., Tseng, C.-H., Choi, E.-K., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.036 · Cited by 499
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
Taylor, M. R. G., Fain, P. R., Sinagra, G., Robinson, M. L., Robertson, A. D., Carniel, E., Di Lenarda, A., Bohlmeyer, T. J., Ferguson, D. A., Brodsky, G. L., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02954-6 · Cited by 492 · cited 1×
“Electrophysiological abnormalities (conduction system block and atrial fibrillation) often precede DCM that relentlessly progresses to HF [6, 7].”
Self-citationRoberts, A. M., Ware, J. S., Herman, D. S., Schafer, S., Baksi, J., Bick, A. G., Buchan, R. J., Walsh, R., John, S., Wilkinson, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010134 · Cited by 491
Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., Helio, T., Keren, A., McKenna, W. J., Monserrat, L., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq271 · Cited by 488
Puntmann, V. O., Voigt, T., Chen, Z., Mayr, M., Karim, R., Rhode, K., Pastor, A., Carr-White, G., Razavi, R., Schaeffter, T., et al. (2013) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2012.08.019 · Cited by 487
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Ortiz-Genga, M. F., Cuenca, S., Dal Ferro, M., Zorio, E., Salgado-Aranda, R., Climent, V., Padrón-Barthe, L., Duro-Aguado, I., Jiménez-Jáimez, J., Hidalgo-Olivares, V. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.927 · Cited by 487
Self-citationOchiai, Y., McCarthy, P. M., Smedira, N. G., Banbury, M. K., Navia, J. L., Feng, J., Hsu, A. P., Yeager, M. L., Buda, T., Hoercher, K. J., et al. (2002) · Circulation · doi:10.1161/01.cir.0000032906.33237.1c · Cited by 479
Genetic mutations and mechanisms in dilated cardiomyopathy
McNally, E. M., Golbus, J. R., & Puckelwartz, M. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62862 · Cited by 478
Clinical and genetic issues in familial dilated cardiomyopathy
Burkett, E. L., & Hershberger, R. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.066 · Cited by 476
van Berlo, J. H., de Voogt, W. G., van der Kooi, A. J., van Tintelen, J. P., Bonne, G., Yaou, R. B., Duboc, D., Rossenbacker, T., Heidbüchel, H., de Visser, M., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0589-1 · Cited by 472
Nazarian, S., Bluemke, D. A., Lardo, A. C., Zviman, M. M., Watkins, S. P., Dickfeld, T. L., Meininger, G. R., Roguin, A., Calkins, H., Tomaselli, G. F., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.549659 · Cited by 471 · cited 1×
“A relationship between patterns of myocardial scar and arrhythmogenesis was also suggested: a scar with a transmurality of 26–75% is predictive of inducible ventricular tachycardia [43].”
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
Karamitsos, T. D., Francis, J. M., Myerson, S., Selvanayagam, J. B., & Neubauer, S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.094 · Cited by 467
van der Zwaag, P. A., van Rijsingen, I. A. W., Asimaki, A., Jongbloed, J. D. H., van Veldhuisen, D. J., Wiesfeld, A. C. P., Cox, M. G. P. J., van Lochem, L. T., de Boer, R. A., Hofstra, R. M. W., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs119 · Cited by 465
Lok, D. J. A., Van Der Meer, P., de la Porte, P. W. B.-A., Lipsic, E., Van Wijngaarden, J., Hillege, H. L., & van Veldhuisen, D. J. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0125-y · Cited by 465
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm456 · Cited by 464
Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates.
Smith, S. C., Ladenson, J. H., Mason, J. W., & Jaffe, A. S. (1997) · PubMed · Cited by 463
CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis
Greulich, S., Deluigi, C. C., Gloekler, S., Wahl, A., Zürn, C., Kramer, U., Nothnagel, D., Bültel, H., Schumm, J., Grün, S., et al. (2013) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2012.10.021 · Cited by 462
Ferreira, V. M., Piechnik, S. K., Dall'Armellina, E., Karamitsos, T. D., Francis, J. M., Choudhury, R. P., Friedrich, M. G., Robson, M. D., & Neubauer, S. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-42 · Cited by 460
Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene
Dalakas, M. C., Park, K.-Y., Semino-Mora, C., Lee, H. S., Sivakumar, K., & Goldfarb, L. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421104 · Cited by 453
Guidelines for the study of familial dilated cardiomyopathies
Mestroni, L. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1145 · Cited by 446
Elevations of Cardiac Troponin I Associated With Myocarditis: Experimental and Clinical Correlates
Smith, S. C., Ladenson, J. H., Mason, J. W., & Jaffe, A. S. (1997) · Circulation · doi:10.1161/01.cir.95.1.163 · Cited by 446
Desmin Mutation Responsible for Idiopathic Dilated Cardiomyopathy
Li, D., Tapscoft, T., Gonzalez, O., Burch, P. E., Quiñones, M. A., Zoghbi, W. A., Hill, R., Bachinski, L. L., Mann, D. L., & Roberts, R. (1999) · Circulation · doi:10.1161/01.cir.100.5.461 · Cited by 445
Mullens, W., Borowski, A. G., Curtin, R. J., Thomas, J. D., & Tang, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.779223 · Cited by 444
Rapezzi, C., Arbustini, E., Caforio, A. L. P., Charron, P., Gimeno-Blanes, J., Helio, T., Linhart, A., Mogensen, J., Pinto, Y., Ristic, A., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs397 · Cited by 439
Self-citationLancellotti, P., Pellikka, P. A., Budts, W., Chaudhry, F. A., Donal, E., Dulgheru, R., Edvardsen, T., Garbi, M., Ha, J.-W., Kane, G. C., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew190 · Cited by 438
Frequency and Phenotypes of Familial Dilated Cardiomyopathy
Grünig, E., Tasman, J. A., Kücherer, H., Franz, W., Kübler, W., & Katus, H. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00434-8 · Cited by 435
Merlo, M., Pyxaras, S. A., Pinamonti, B., Barbati, G., Di Lenarda, A., & Sinagra, G. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.030 · Cited by 430
Self-citationSignificance of ventricular arrhythmias in idiopathic dilated cardiomyopathy
Meinertz, T., Hofmann, T., Kasper, W., Treese, N., Bechtold, H., Stenen, U., Pop, T., Leitner, E.-R. V., Andresen, D., & Meyer, J. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90522-8 · Cited by 426
Di Marco, A., Anguera, I., Schmitt, M., Klem, I., Neilan, T. G., White, J. A., Sramko, M., Masci, P. G., Barison, A., Mckenna, P., et al. (2017) · JACC: Heart Failure · doi:10.1016/j.jchf.2016.09.017 · Cited by 422
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Shadrin, I. Y., Allen, B. W., Qian, Y., Jackman, C. P., Carlson, A. L., Juhas, M. E., & Bursac, N. (2017) · Nature Communications · doi:10.1038/s41467-017-01946-x · Cited by 420
Cardiovascular manifestations of systemic lupus erythematosus
Doherty, N. E., & Siegel, R. J. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90023-7 · Cited by 418
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
Dennert, R., Crijns, H. J., & Heymans, S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn296 · Cited by 411 · cited 1×
“Molecular detection of viral genomic sequences in diseased myocardium is also feasible and, when coupled with immunohistochemical analysis, increases the diagnostic accuracy of EMB in addition to providing an aetiology and offering prognostic information [5, 27, 28].”
BackgroundGuidelines for autopsy investigation of sudden cardiac death
on behalf of the Association for European Cardiovascular Pathology, Basso, C., Burke, M., Fornes, P., Gallagher, P. J., de Gouveia, R. H., Sheppard, M., Thiene, G., & van der Wal, A. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0505-5 · Cited by 409 · cited 1×
“In case of proband’s death, postmortem molecular analyses can be useful to detect the disease-causing mutation in addition to an accurate histological and morphological evaluation of the heart in order to clarify the disease phenotype [14].”
Risk stratification for sudden cardiac death: Current status and challenges for the future
Wellens, H. J. J., Schwartz, P. J., Lindemans, F. W., Buxton, A. E., Goldberger, J. J., Hohnloser, S. H., Huikuri, H. V., Kaab, S., La Rovere, M. T., Malik, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu176 · Cited by 405
Real-Time 3-Dimensional Echocardiographic Quantification of Left Ventricular Volumes
Mor-Avi, V., Jenkins, C., Kühl, H. P., Nesser, H.-J., Marwick, T., Franke, A., Ebner, C., Freed, B. H., Steringer-Mascherbauer, R., Pollard, H., et al. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.02.009 · Cited by 393
Dinov, B., Fiedler, L., Schönbauer, R., Bollmann, A., Rolf, S., Piorkowski, C., Hindricks, G., & Arya, A. (2014) · Circulation · doi:10.1161/circulationaha.113.003063 · Cited by 390
White, J. A., Yee, R., Yuan, X., Krahn, A., Skanes, A., Parker, M., Klein, G., & Drangova, M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.046 · Cited by 386
Halliday, B. P., Gulati, A., Ali, A., Guha, K., Newsome, S., Arzanauskaite, M., Vassiliou, V. S., Lota, A., Izgi, C., Tayal, U., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026910 · Cited by 384
Assessment of Left Ventricular Dyssynchrony by Speckle Tracking Strain Imaging
Delgado, V., Ypenburg, C., van Bommel, R. J., Tops, L. F., Mollema, S. A., Marsan, N. A., Bleeker, G. B., Schalij, M. J., & Bax, J. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.040 · Cited by 378
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure
Ky, B., French, B., McCloskey, K., Rame, J. E., McIntosh, E., Shahi, P., Dries, D. L., Tang, W. H. W., Wu, A. H. B., Fang, J. C., et al. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.958223 · Cited by 376
Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations
Meune, C., Van Berlo, J. H., Anselme, F., Bonne, G., Pinto, Y. M., & Duboc, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052632 · Cited by 369
Mutations in Ribonucleic Acid Binding Protein Gene Cause Familial Dilated Cardiomyopathy
Brauch, K. M., Karst, M. L., Herron, K. J., de Andrade, M., Pellikka, P. A., Rodeheffer, R. J., Michels, V. V., & Olson, T. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.038 · Cited by 368 · cited 7×
“The improved outcomes in DCM are paralleled by a higher rate of LV reverse remodeling (LVRR): in recent years several studies revealed that almost 40% of patients experience a significant LVRR when treated with evidence-based pharmacological and device treatments [26].”
InfluentialHsia, H. H., Callans, D. J., & Marchlinski, F. E. (2003) · Circulation · doi:10.1161/01.cir.0000083725.72693.ea · Cited by 368
Titin-truncating variants affect heart function in disease cohorts and the general population
Schafer, S., de Marvao, A., Adami, E., Fiedler, L. R., Ng, B., Khin, E., Rackham, O. J. L., van Heesch, S., Pua, C. J., Kui, M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3719 · Cited by 362
Cardiovascular risks and benefits of moderate and heavy alcohol consumption
Fernández-Solà, J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.91 · Cited by 360
Norton, N., Li, D., Rieder, M. J., Siegfried, J. D., Rampersaud, E., Züchner, S., Mangos, S., Gonzalez-Quintana, J., Wang, L., McGee, S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.01.016 · Cited by 358
Arbustini, E., Pilotto, A., Repetto, A., Grasso, M., Negri, A., Diegoli, M., Campana, C., Scelsi, L., Baldini, E., Gavazzi, A., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01724-2 · Cited by 358 · cited 1×
“However, they are more prevalent (≈33%) in patients with a DCM+E phenotype.(26)”
Direct T2 Quantification of Myocardial Edema in Acute Ischemic Injury
Verhaert, D., Thavendiranathan, P., Giri, S., Mihai, G., Rajagopalan, S., Simonetti, O. P., & Raman, S. V. (2011) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.09.023 · Cited by 352
Cano, O., Hutchinson, M., Lin, D., Garcia, F., Zado, E., Bala, R., Riley, M., Cooper, J., Dixit, S., Gerstenfeld, E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.032 · Cited by 350
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
Hilfiker-Kleiner, D., Haghikia, A., Berliner, D., Vogel-Claussen, J., Schwab, J., Franke, A., Schwarzkopf, M., Ehlermann, P., Pfister, R., Michels, G., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx355 · Cited by 348
Stelken, A. M., Younis, L. T., Jennison, S. H., Douglas Miller, D., Miller, L. W., Shaw, L. J., Kargl, D., & Chaitman, B. R. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00464-5 · Cited by 342
Gulati, A., Ismail, T. F., Jabbour, A., Alpendurada, F., Guha, K., Ismail, N. A., Raza, S., Khwaja, J., Brown, T. D. H., Morarji, K., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002518 · Cited by 342
Klem, I., Weinsaft, J. W., Bahnson, T. D., Hegland, D., Kim, H. W., Hayes, B., Parker, M. A., Judd, R. M., & Kim, R. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.070 · Cited by 331
Evolving Concepts in Dilated Cardiomyopathy
Merlo, M., Cannatà, A., Gobbo, M., Stolfo, D., Elliott, P. M., & Sinagra, G. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1103 · Cited by 331
Self-citationGoldenberg, I., Moss, A. J., Hall, W. J., Foster, E., Goldberger, J. J., Santucci, P., Shinn, T., Solomon, S., Steinberg, J. S., Wilber, D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.014324 · Cited by 328
Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping
Thavendiranathan, P., Walls, M., Giri, S., Verhaert, D., Rajagopalan, S., Moore, S., Simonetti, O. P., & Raman, S. V. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.111.967836 · Cited by 324
Filamins in cell signaling, transcription and organ development
Zhou, A.-X., Hartwig, J. H., & Akyürek, L. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.001 · Cited by 319
Update 2011: Clinical and Genetic Issues in Familial Dilated Cardiomyopathy
Hershberger, R. E., & Siegfried, J. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.015 · Cited by 319
Predictors of Mortality in Chronic Chagas Disease: A Systematic Review of Observational Studies
Rassi, A., Rassi, A., & Rassi, S. G. (2007) · Circulation · doi:10.1161/circulationaha.106.627265 · Cited by 315 · cited 1×
“New York Heart Association (NYHA) functional class, left ventricular systolic function, cardiomegaly, and non-sustained ventricular tachycardia have been consistently identified as important prognostic markers [14].”
BackgroundMitraClip® Therapy in Patients with End-Stage Systolic Heart Failure
Franzen, O., van der Heyden, J., Baldus, S., Schlüter, M., Schillinger, W., Butter, C., Hoffmann, R., Corti, R., Pedrazzini, G., Swaans, M. J., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr029 · Cited by 313
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
Ware, J. S., Amor-Salamanca, A., Tayal, U., Govind, R., Serrano, I., Salazar-Mendiguchía, J., García-Pinilla, J. M., Pascual-Figal, D. A., Nuñez, J., Guzzo-Merello, G., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.462 · Cited by 310
Lancellotti, P., Pellikka, P. A., Budts, W., Chaudhry, F. A., Donal, E., Dulgheru, R., Edvardsen, T., Garbi, M., Ha, J. W., Kane, G. C., et al. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.10.016 · Cited by 310
Iles, L., Pfluger, H., Lefkovits, L., Butler, M. J., Kistler, P. M., Kaye, D. M., & Taylor, A. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.062 · Cited by 309
Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers
Kumar, S., Baldinger, S. H., Gandjbakhch, E., Maury, P., Sellal, J.-M., Androulakis, A. F. A., Waintraub, X., Charron, P., Rollin, A., Richard, P., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.058 · Cited by 307
The Cardiac Desmosome and Arrhythmogenic Cardiomyopathies: From Gene to Disease
Delmar, M., & McKenna, W. J. (2010) · Circulation Research · doi:10.1161/circresaha.110.223412 · Cited by 307
Feingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000526 · Cited by 306
T1 Mapping in Cardiomyopathy at Cardiac MR: Comparison with Endomyocardial Biopsy
Sibley, C. T., Noureldin, R. A., Gai, N., Nacif, M. S., Liu, S., Turkbey, E. B., Mudd, J. O., van der Geest, R. J., Lima, J. A. C., Halushka, M. K., et al. (2012) · Radiology · doi:10.1148/radiol.12112721 · Cited by 303
Schultheiss, H.-P., Kuhl, U., & Cooper, L. T. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr165 · Cited by 301
Mooij, C. F., de Wit, C. J., Graham, D. A., Powell, A. J., & Geva, T. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21407 · Cited by 297 · cited 2×
“CMR is considered the gold standard for noninvasive assessment of RV function [7, 8].”
Athlete's Heart and Cardiovascular Care of the Athlete: Scientific and Clinical Update
Baggish, A. L., & Wood, M. J. (2011) · Circulation · doi:10.1161/circulationaha.110.981571 · Cited by 296
Moon, J. C. C., Lorenz, C. H., Francis, J. M., Smith, G. C., & Pennell, D. J. (2002) · Radiology · doi:10.1148/radiol.2233011181 · Cited by 294 · cited 1×
“SSFP cine imaging is currently regarded as the gold standard imaging technique for the evaluation of LV volume and systolic function [1, 2], as it is not affected by the geometric assumptions used in 2D echocardiography for the LV (such as the area-length method) [3] (Fig.”
Holmes, J., Kubo, S. H., Cody, R. J., & Kligfield, P. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90317-0 · Cited by 293
In Vivo Cellular Reprogramming: The Next Generation
Srivastava, D., & DeWitt, N. (2016) · Cell · doi:10.1016/j.cell.2016.08.055 · Cited by 292
Research works printed but not linked: 77
- [426]Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010;122:900-9.
- [428]Chimenti C, Frustaci A. Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation. 2013;128:1531-41.
- [435]Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;128(16):e240-327.
- [437]Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Wojciechowska C, Glanowska G, Wilczewski P, et al. Randomized, placebo-controlled study for immunosuppressive treat- ment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104(1):39-45.
- [447]Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113:876-90.
- [448]Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocar- ditis. J Am Coll Cardiol. 2012;59:779-92.
- [454]Towbin JA, Lorts A. Arrhythmias and dilated cardiomyopathy common pathogenetic path- ways? J Am Coll Cardiol. 2011;57(21):2169-71.
- [478]Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-30.
- [482]Goldberger JJ, Subačius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63(18):1879-89.
- [484]Arbustini E, Disertori M, Narula J. Primary prevention of sudden arrhythmic death in dilated cardiomyopathy current guidelines and risk stratification. JACC Heart Fail. 2017;5(1):39-43.
- [486]van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59(5):493-500.
- [487]Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure. Am J Med. 1949;7(4):478-89.
- [488]Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol. 1996;19(1):95-106.
- [489]Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. J Am Coll Cardiol. 2015;66(15):1714-28.
- [493]Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637-44.
- [494]Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358(25):2667-77.
- [497]Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340-7.
- [498]Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498-505.
- [500]Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417-27.
- [504]Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120(22):2170-6.
- [506]Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta- blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295(2):165-71.
- [516]Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E, et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol. 2010;55(21):2355-65.
- [521]Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy. Circulation. 2014;129:728-36.
- [522]Oloriz T, Silberbauer J, Maccabelli G, Mizuno H, Baratto F, Kirubakaran S, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus infero- lateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7(3):414-23.
- [523]Dinov B, Arya A, Schratter A, Schirripa V, Fiedler L, Sommer P, et al. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality? Circ Arrhythm Electrophysiol. 2015;8(3):598-605.
- [524]Yu R, Ma S, Tung R, Stevens S, Macias C, Bradfield J, et al. Catheter ablation of scar-based ventricular tachycardia: relationship of procedure duration to outcomes and hospital mortality. Heart Rhythm. 2015;12(1):86-94.
- [525]Gökoğlan Y, Mohanty S, Gianni C, Santangeli P, Trivedi C, Güneş MF, et al. Scar homog- enization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2016;68(18):1990-8.
- [526]Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD, et al. Acute hemo- dynamic decompensation during catheter ablation of scar-related ventricular tachycardia: inci- dence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8(1):68-75.
- [527]Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergo- ing catheter ablation of scar-related ventricular tachycardia: a propensity-matched analysis. Heart Rhythm. 2018;15(10):1500-6.
- [529]Piers SR, Tao Q, van Huls van Taxis CF, Schalij MJ, van der Geest RJ, Zeppenfeld K. Contrast- enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonisch- emic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol. 2013;6(5):875-83.
- [530]Hayashi T, Santangeli P, Pathak RK, Muser D, Liang JJ, Castro SA, et al. Outcomes of catheter ablation of idiopathic outflow tract ventricular arrhythmias with an R wave pattern break in lead V2: a distinct clinical entity. J Cardiovasc Electrophysiol. 2017;28(5):504-14.
- [531]Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J. Electrocardiographic rec- ognition of the epicardial origin of ventricular tachycardias. Circulation. 2004;109(15):1842-7.
- [532]Shun-Shin MJ, Zheng SL, Cole GD, Howard JP, Whinnett ZI, Francis DP. Implantable car- dioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials. Eur Heart J. 2017;38(22):1738-46.
- [571]Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and prog- nostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011;57:1468-76. https://doi.org/10.1016/j. jacc.2010.11.030. · doi:10.1016/j
- [604]Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, et al. Myocarditis in clinical practice. Mayo Clin Proc. 2016;91(9):1256-66. https://doi.org/10.1016/j. mayocp.2016.05.013. · doi:10.1016/j
- [653]Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. JAMA. 1996;276(3):199.
- [658]Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-455.
- [667]Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guide- lines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. https://doi.org/10.1093/eurheartj/ ehw128. · doi:10.1093/eurheartj/
- [677]McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin- neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. https://doi.org/10.1056/NEJMoa1409077. · DOI · Paper page
- [687]Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defi- brillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-8.
- [689]Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, et al. Defibrillator implanta- tion in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-30. https://doi.org/10.1056/NEJMoa1608029. · DOI · Paper page
- [692]Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. Department of Veterans Affairs Survival Trial of antiarrhythmic therapy in congestive heart failure. QRS duration and mortal- ity in patients with congestive heart failure. Am Heart J. 2002;143(6):1085-91.
- [706]Stolfo D, Merlo M, Pinamonti B, Poli S, Gigli M, Barbati G, et al. Early improvement of func- tional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015;115(8):1137-43. https://doi.org/10.1016/j.amjcard.2015.01.549. · DOI
- [718]Merlo M, Anzini M, Bussani R, Artico J, Barbati G, Stolfo D, et al. Characterization and long- term prognosis of postmyocarditic dilated cardiomyopathy compared with idiopathic dilated cardiomyopathy. Am J Cardiol. 2016;118:895-900.
- [726]Priori SG, Blomström-Lundqvist C, Mazzanti A. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;8:746-837.
- [728]Dal Ferro M, Stolfo D, Altinier A, Gigli M, Perrieri M, Ramani F, et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart. 2017;103:1704-10.
- [735]Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10:531-47.
- [736]Menon SC, Michels VV, Pellikka PA, Ballew JD, Karst ML, Herron KJ, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet. 2008;74:445-54.
- [737]Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Personalizing risk stratification for sud- den death in dilated cardiomyopathy. Circulation. 2017;136:215-31.
- [740]Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycar- dia-AMIOVIRT. J Am Coll Cardiol. 2003;41:1707-12.
- [741]Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibril- lator implantation in patients with nonischemic dilated cardiomyopathy for the defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. N Engl J Med. 2004;350:2151-8.
- [742]Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implant- able cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
- [743]Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221-30.
- [745]Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JGF, et al. Prediction of mode of death in heart failure: the Seattle heart failure model. Circulation. 2007;116:392-8.
- [747]Spezzacatene A, Sinagra G, Merlo M, Barbati G, Graw SL, Brun F, et al. Arrhythmogenic phe- notype in dilated cardiomyopathy: natural history and predictors of life-threatening arrhyth- mias. J Am Heart Assoc. 2015;4:e002149.
- [750]Van Rijsingen IAW, Van Der Zwaag PA, Groeneweg JA, Nannenberg EA, Jongbloed JDH, Zwinderman AH, et al. Outcome in phospholamban R14del carriers results of a large multi- centre cohort study. Circ Cardiovasc Genet. 2014;7:455-65.
- [754]Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896-908.
- [755]Di Marco A, Anguera I, Schmitt M, Klem I, Neilan T, White JA, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopa- thy: systematic review and meta-analysis. JACC Heart Fail. 2017;5:28-38.
- [758]Merlo M, Gobbo M, Stolfo D, Losurdo P, Ramani F, Barbati G, et al. The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging. 2016;9:1034-42.
- [760]Goldberger JJ, Subačius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63:1879-89.
- [761]Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, et al. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Am J Cardiol. 2012;109:729-35.
- [762]Losurdo P, Stolfo D, Merlo M, Barbati G, Gobbo M, Gigli M, et al. Early arrhythmic events in idiopathic dilated cardiomyopathy. JACC Clin Electrophysiol. 2016;2:535-43.
- [763]Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, et al. Use of the wear- able cardioverter defibrillator in high-risk cardiac patients data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry). Circulation. 2015;132:1613-9.
- [765]Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014;16:317-24.
- [766]McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin- neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993-1004.
- [768]Hare JM, DiFede DL, Castellanos AM, Florea V, Landin AM, El-Khorazaty J, et al. Randomized comparison of allogeneic vs. autologous mesenchymal stem cells for non-ischemic dilated car- diomyopathy: POSEIDON-DCM trial. J Am Coll Cardiol. 2017;69:526-37.
- [769]Woitek F, Zentilin L, Hoffman NE, Powers JC, Ottiger I, Parikh S, et al. Intracoronary cyto- protective gene therapy: a study of VEGF-B167 in a pre-clinical animal model of dilated car- diomyopathy. J Am Coll Cardiol. 2015;66:139-53.
- [771]Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67:2996-3010.
- [775]Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-24.
- [781]Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391:82-94.
- [783]de Andrade JP, Marin Neto JA, de Paola AAV, Vilas-Boas F, Oliveira GMM, Bacal F, et al. I Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011;96:434-42.
- [784]Rassi A, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease. Circulation. 2007;115:1101-9.
- [785]Fish AE, Pride YB, Pinto DS. Lyme carditis. Infect Dis Clin North Am. 2008;22:275-88.
- [800]Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopa- thy. N Engl J Med. 2000;342:1077-84.
- [801]Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 European Society of Cardiology position paper on cancer treatments and cardiovas- cular toxicity. Eur Heart J. 2016;37:2768-801.
- [804]Ware JS, Amor-salamanca A, Tayal U, Govind R, Serrano I, Pascual-figal DA, et al. Genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol. 2018;71:2293-302.
- [811]Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardio- myopathy. World J Cardiol. 2014;6:771-81.
Cited by
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments
Orphanou, N., Papatheodorou, E., & Anastasakis, A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10139-0 · Cited by 137
Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity
Cullen, M. R., Lemeshow, A. R., Russo, L., Barnes, D. M., Ababio, Y., & Habtezion, A. (2022) · Healthcare · doi:10.3390/healthcare10040603 · Cited by 59
Inherited Arrhythmias in the Pediatric Population: An Updated Overview
Mariani, M. V., Pierucci, N., Fanisio, F., Laviola, D., Silvetti, G., Piro, A., Fazia, V. M. L., Chimenti, C., Rebecchi, M., Drago, F., et al. (2024) · Medicina · doi:10.3390/medicina60010094 · Cited by 46
“VA is infrequently found to be the root of HF in children [110].”
BackgroundRisk stratification in cardiomyopathy
Sinagra, G., Carriere, C., Clemenza, F., Minà, C., Bandera, F., Zaffalon, D., Gugliandolo, P., Merlo, M., Guazzi, M., & Agostoni, P. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320961898 · Cited by 37
Self-citationDilated cardiomyopathy: a new insight into the rare but common cause of heart failure
Giri, P., Mukhopadhyay, A., Gupta, M., & Mohapatra, B. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10125-6 · Cited by 33
Metadata
- Authors
- Sinagra, G., Merlo, M., & Pinamonti, B.
- Affiliations
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- ORCID
- Gianfranco Sinagra
- Venue
- Springer eBooks
- Publisher
- Springer International Publishing
- Published
- 2019
- OpenAlex
- W4313642785
- Cited by
- 32
- References
- 603
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 9 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 2
- FWCI
- 5.48
- Type
- book
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Springer eBooks (publishedVersion, cc-by)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- Directory of Open access Books (OAPEN Foundation) (submittedVersion, cc-by)
- Funders
- ACRC - Associazione Culturale per la Ricerca in Cardioscienze
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- dilated cardiomyopathy, pathophysiology, differential diagnosis, clinical management, genetic testing, cardiac arrhythmias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.